Glyrx-pf Injection, Solution
Product Images NDC 51754-6000
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glyrx-pf (NDC 51754-6000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Exela Pharma Sciences, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Exela Logo (Image 02)
1 mL Carton (Image 03)
1 mL Vial (Image 04)
2 mL Vial (Image 05)
2 mL Carton (Image 06)
Image 07
Image 08
This is a description for a medication in a solution form. The solution contains 0.2 mg of Glycopyrrolate and 9mg of Sodium Chloride in water for injection. The pH level is adjusted using Sodium Hydroxide and/or Hydrochloric Acid and the pH level remains between 2.0-3.0. It is stored at a controlled room temperature of 20°C to 25°C. The Exela Pharma Sciences company manufactures and distributes the medicine in Lenoir, NC 28645 USA.*
Image 09
This is a medication label for two injectable medicines, Glycopyrrolate and Falseness, used for different purposes and given in different doses. The label mentions the concentration of the medicines and some of the inactive ingredients used in the preparation. It also includes instructions for handling and storage, and a precaution to discard unused injections.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.